Clinical trials in the Eurasian Economic Union

Why the European Union Should Talk with the Eurasian Economic Union

Eurasian Economic Union Foundation: Issues of Global Regionalization

This paper is devoted to the theoretical conceptualization of political-economic processes within the Eurasian Economic Union. The author elaborates on this project within the framework of “global regionalization” and regards it as a fledging “global region.” In this paper, the European Union is analyzed as a model of the existing global region. The Eurasian region also has its own specific tra...

Regionalism and its Economic Effects on Iran in a Computable General Equilibrium (CGE) Model:A Case Study of the Eurasian Economic Union (EAEU)

Over the last three decades, membership in regional trade arrangements has become one of the most important tools of trade diplomacy. Regional agreements bring a lot of benefits for the member countries through reducing barriers and restrictions. Considering the signing of the Interim PTA Agreement between Iran and Eurasia and its effects, this study aimed to investigate the economic effects of...

Economic endpoints in clinical trials.

Economic endpoints are increasingly common in randomized clinical trials. As a relatively new addition to the field, methods of measuring and analyzing cost data are still evolving. These developments will be stimulated by the demands of the public for efficient and effective medical care, which will be based on the findings of clinical trials.

Economic evaluations in cancer clinical trials

Authors: Stephen Goodall and Rosalie Viney Prepared: July 2011 SUMMARY • The aim of economic evaluation is to inform clinical and health system decision making and policy • Every time a decision is made about a new technology or treatment, a decision is also made about resource allocation • Economic evaluation is a formal and systematic comparison of the costs and benefits associated with two o...